JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB266474

Human TP53INP2 knockout HEK-293T cell line

Be the first to review this product! Submit a review

|

(0 Publication)

TP53INP2 KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 4.

View Alternative Names

C20orf110, DOR, Diabetes and obesity regulated; p53 inducible protein U, PINH, T53I2_HUMAN, Tumor protein p53-inducible nuclear protein 2, p53-inducible protein U

1 Images
Sanger Sequencing - Human TP53INP2 knockout HEK-293T cell line (AB266474)
  • Sanger seq

Unknown

Sanger Sequencing - Human TP53INP2 knockout HEK-293T cell line (AB266474)

Homozygous : 1 bp insertion in exon4

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 4

Product details

Recommended control: Human wild-type HEK293T cell line (ab255449). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266474-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266474 Human TP53INP2 knockout HEK-293T cell line", "number":"AB266474-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266474-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266474 Human TP53INP2 knockout HEK-293T cell line", "number":"AB266474-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
TP53INP2
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

TP53INP2 also known as p53-inducible nuclear protein 2 is a 104 amino acids protein with a molecular weight of approximately 12 kDa. This protein actively engages in the regulation of autophagy and transcription processes. It is mainly expressed in human tissues like the brain liver heart and pancreas. In cellular environments TP53INP2 moves between the nucleus and the cytoplasm which suggests it plays a dynamic role in cellular homeostasis by potentially interacting with different cellular structures.
Biological function summary

TP53INP2 plays a significant role in modulating the cellular stress response and apoptosis. It interacts with autophagy-related proteins to facilitate the degradation of damaged cellular components. TP53INP2 is not generally described as part of a larger protein complex but its interactions with several autophagy-related proteins underline its involvement in cellular cleaning and recycling systems aiding in the balance between cell survival and cell death.

Pathways

TP53INP2 connects to both the autophagy and apoptosis pathways. Within the autophagy pathway TP53INP2 collaborates with proteins like LC3 and Beclin-1 to promote the formation of autophagosomes. Meanwhile in apoptosis pathways TP53INP2 affects the activity of the tumor suppressor protein p53 providing a link between autophagic processes and programmed cell death especially under cellular stress conditions.

TP53INP2 correlates with cancer and neurodegenerative diseases. In cancer the interaction with p53 signifies a role in tumorigenesis where altered TP53INP2 expression might contribute to cancer progression. In neurodegenerative disorders such as Alzheimer's disease the role of TP53INP2 in autophagy becomes essential as impaired autophagy is often linked with such diseases. The protein's connections to key mechanisms suggest its potential as a therapeutic target in diseases where autophagy and cell death processes are disrupted.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com